Who Paid My Doc
Sinuva
Drug Otolaryngology (Ear, Nose, Throat)
General payments
$685,013
Research payments
$21,444
Through program year 2025, $685,013 in general payments and $21,444 in research payments were reported against Sinuva (Otolaryngology (Ear, Nose, Throat)).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $6 | 1 |
| 2021 | General | $216,572 | 1,992 |
| 2020 | General | $57,177 | 1,137 |
| 2019 | General | $411,258 | 2,316 |
| 2019 | Research | $21,444 | 23 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
5,446 general · 23 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.